S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Knox Systems and Microsoft Streamline Federal Cloud Compliance

Navigating the labyrinth of federal security compliance often traps innovative software firms in years of administrative limbo. A new partnership between Knox Systems and Microsoft aims to shatter this bottleneck, allowing commercial technology providers to deploy secure, production-ready solutions on the Azure Government Cloud in just 90 days.

Knox Systems and Microsoft Streamline Federal Cloud Compliance
Photo: Bio & News

The collaboration leverages Knox’s pre-authorized Federal Managed Cloud to shoulder the burden of security controls, effectively handing companies a shortcut to the U.S. government market. By inheriting existing authorizations, software vendors can bypass the typical multi-year compliance cycle that currently prevents agencies from accessing the latest advancements in AI, cybersecurity, and enterprise data tools.

Irina Denisenko, CEO of Knox Systems, argues that the current friction keeps critical commercial innovation out of reach for defense and civilian missions. Her firm, which currently supports over 70 software providers, including Adobe and Armis, maintains 16 federal and Department of War Authorizations to Operate. By integrating this infrastructure with Microsoft’s trusted cloud environment, the companies intend to standardize a path for vendors to bring production workloads to government customers at a pace previously unattainable in the public sector.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!